<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="" /><title>Captopril formulations [unlicensed]: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1144-captopril-formulations-unlicensed.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1144-captopril-formulations-unlicensed.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1144-captopril-formulations-unlicensed.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1034-hypertension-and-heart-failure.htm">2.5 Hypertension and heart failure</a> &gt; <a href="PHP1122-drugs-affecting-the-renin-angiotensin-system.htm">2.5.5 Drugs affecting the renin-angiotensin system</a> &gt; <a href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm">2.5.5.1 Angiotensin-converting enzyme inhibitors</a> &gt; <a href="PHP1138-captopril.htm">CAPTOPRIL</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm" title="Previous: 2.5.5.1 Angiotensin-converting enzyme inhibitors">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1145-cilazapril.htm" title="Next: CILAZAPRIL">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382823.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Renin-Angiotensin-Aldosterone System Inhibitors 24:32 &gt; Angiotensin-Converting Enzyme Inhibitors 24:32.04</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/856-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Captopril</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Captopril</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="PHP1138-captopril.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CAPTOPRIL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors</p></div></li><li><a href="PHP1139-captopril-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors &gt; CAPTOPRIL</p></div></li><li><a href="PHP1140-capoten.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Capoten®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors &gt; CAPTOPRIL</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22captopril%22%22captopril%22%22captopril%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11594-captopril.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CAPTOPRIL</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11595-captopril-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors &gt; CAPTOPRIL</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11596-capoten.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Capoten®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.1 Angiotensin-converting enzyme inhibitors &gt; CAPTOPRIL</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c05-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0037.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/856-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01774.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c26-sec1-001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Molecular structure and properties</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 4: Pharmaceutics &gt; 26 Molecular Structure, Properties, and States of Matter</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c70-sec1-005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanisms of Drug Interaction</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 7: Fundamentals of Pharmacy Practice &gt; 70 Drug Interactions</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-C31.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; C</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22captopril%22%22captopril%22%22captopril%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E26E3E0R0D1177.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Captopril</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c66.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Captopril</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; C</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>CAPTOPRIL</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int3-captopril.htm">Captopril</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">mild to moderate essential hypertension alone or with thiazide therapy and severe hypertension resistant to other treatment; congestive heart failure with left ventricular dysfunction (adjunct—see <a title=" Drugs affecting the renin-angiotensin system" href="PHP1122-drugs-affecting-the-renin-angiotensin-system.htm">section 2.5.5</a>); following myocardial infarction, see dose; diabetic nephropathy (microalbuminuria greater than 30 mg/day) in type 1 diabetes</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: ACE inhibitors cautions" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1129">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="target-block: ACE inhibitors contra-indications" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1132">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">see <a title="BNF:target-block: ACE inhibitors and renal impairment" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1134">notes above</a>; reduce dose; max. initial dose 25 mg daily (do not exceed 100 mg daily) if eGFR 20–40 mL/minute/1.73 m<sup>2</sup>; max. initial dose 12.5 mg daily (do not exceed 75 mg daily) if eGFR 10–20 mL/minute/1.73 m<sup>2</sup>; max. initial dose 6.25 mg daily (do not exceed 37.5 mg daily) if eGFR less than 10 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="BNF:target-block: ACE inhibitors and pregnancy" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1135">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: ACE inhibitors and breast-feeding" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1136">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see notes above; tachycardia, serum sickness, weight loss, stomatitis, maculopapular rash, photosensitivity, flushing and acidosis</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Hypertension, used alone, initially 12.5 mg twice daily; if used in addition to diuretic (<a title="BNF:target-block: Concomitant diuretics" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1131">see notes above</a>), or in elderly, initially 6.25 mg twice daily (first dose at bedtime); usual maintenance dose 25 mg twice daily; max. 50 mg twice daily (rarely 3 times daily in severe hypertension)</p></li> <li><p>Heart failure (adjunct), initially 6.25–12.5 mg 2–3 times daily under close medical supervision (<a title="BNF:target-block: ACE inhibitors and heart disease" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm#PHP1125">see notes above</a>), increased gradually at intervals of at least 2 weeks up to max. 150 mg daily in divided doses if tolerated</p></li> <li><p>Prophylaxis after infarction in clinically stable patients with asymptomatic or symptomatic left ventricular dysfunction (radionuclide ventriculography or echocardiography undertaken before initiation), initially 6.25 mg, starting as early as 3 days after infarction, then increased over several weeks to 150 mg daily (if tolerated) in divided doses</p></li> <li><p>Diabetic nephropathy, 75–100 mg daily in divided doses; if further blood pressure reduction required, other antihypertensives may be used in conjunction with captopril; in severe renal impairment, initially 12.5 mg twice daily (if concomitant diuretic therapy required, loop diuretic rather than thiazide should be chosen)</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP1139-captopril-non-proprietary.htm#PHP1139-captopril-non-proprietary" title="Captopril">Captopril</a></li><li><a href="PHP1140-capoten.htm#PHP1140-capoten" title="Capoten®">Capoten®</a></li><li id="_PHP1141-with-diuretic_PHP1141-with-diuretic"><a href="PHP1141-with-diuretic.htm#PHP1141-with-diuretic" title="With diuretic">With diuretic</a><ul style="display: none"><li><a href="PHP1142-co-zidocapt-non-proprietary.htm#PHP1142-co-zidocapt-non-proprietary" title="Co-zidocapt">Co-zidocapt</a></li><li><a href="PHP1143-capozide.htm#PHP1143-capozide" title="Capozide®">Capozide®</a></li></ul></li></ul><div id="PHP1144-captopril-formulations-unlicensed" style="margin: 0 0 0 20px;"><h1 class="title">Captopril formulations [unlicensed]</h1><p>Available from <a title="appendix: Special-order Manufacturers" href="PHP10403-special-order-manufacturers.htm">‘special-order’ manufacturers or specialist importing companies</a></p></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1124-angiotensin-converting-enzyme-inhibitors.htm">Previous: 2.5.5.1 Angiotensin-converting enzyme inhibitors</a> | <a class="top" href="PHP1144-captopril-formulations-unlicensed.htm#">Top</a> | <a accesskey="]" href="PHP1145-cilazapril.htm">Next: CILAZAPRIL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>